These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 9820947

  • 1. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
    Gao J, Schwalb TA, Addeo JV, Ghosn CR, Stern ME.
    Cornea; 1998 Nov; 17(6):654-63. PubMed ID: 9820947
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
    Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1356-63. PubMed ID: 10798650
    [Abstract] [Full Text] [Related]

  • 4. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
    Strong B, Farley W, Stern ME, Pflugfelder SC.
    Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
    [Abstract] [Full Text] [Related]

  • 5. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Izci C, Celik I, Alkan F, Erol M, Sur E.
    Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
    [Abstract] [Full Text] [Related]

  • 6. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
    Izci C, Celik I, Alkan F, Ogurtan Z, Ceylan C, Sur E, Ozkan Y.
    Am J Vet Res; 2002 May; 63(5):688-94. PubMed ID: 12013470
    [Abstract] [Full Text] [Related]

  • 7. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
    Fullard RJ, Kaswan RM, Bounous DI, Hirsh SG.
    J Am Optom Assoc; 1995 Jul; 66(7):397-404. PubMed ID: 7560726
    [Abstract] [Full Text] [Related]

  • 8. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
    Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C.
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK, Davidson MG, English RV, Nasisse MP, Jamieson VE, Gerig TM.
    J Am Vet Med Assoc; 1991 Oct 15; 199(8):1039-42. PubMed ID: 1748606
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of HL036 versus Cyclosporine A in the Treatment of Naturally Occurring Canine Keratoconjunctivitis Sicca.
    Lee HB, Choi HJ, Cho SM, Kang S, Ahn HK, Song YJ, Kim YJ, Son WC.
    Curr Eye Res; 2018 Jul 15; 43(7):889-895. PubMed ID: 29634381
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine inhibits apoptosis in experimental murine xerophthalamia conjunctival epithelium.
    Sun J, Wang J.
    J Huazhong Univ Sci Technolog Med Sci; 2006 Jul 15; 26(4):469-71. PubMed ID: 17120751
    [Abstract] [Full Text] [Related]

  • 14. Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Gilger BC, Andrews J, Wilkie DA, Wyman M, Lairmore MD.
    Vet Immunol Immunopathol; 1995 Dec 15; 49(3):199-208. PubMed ID: 8746695
    [Abstract] [Full Text] [Related]

  • 15. Marked depletion of the water-channel protein, AQP5, in the canine nictitating membrane glands might contribute to the development of KCS.
    Terakado K, Yogo T, Kohara Y, Soeta S, Nezu Y, Harada Y, Hara Y, Amasaki H, Tagawa M.
    Vet Pathol; 2013 Jul 15; 50(4):664-7. PubMed ID: 23160543
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
    Ofri R, Lambrou GN, Allgoewer I, Graenitz U, Pena TM, Spiess BM, Latour E.
    Vet J; 2009 Jan 15; 179(1):70-7. PubMed ID: 17950639
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A new perspective on canine keratoconjunctivitis sicca. Treatment with ophthalmic cyclosporine.
    Kaswan RL, Salisbury MA.
    Vet Clin North Am Small Anim Pract; 1990 May 15; 20(3):583-613. PubMed ID: 2194349
    [Abstract] [Full Text] [Related]

  • 19. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K, Balicki I, Szadkowski M.
    Acta Vet Hung; 2018 Jun 15; 66(2):189-203. PubMed ID: 29958527
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.